Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.
NYS Entity Status
NYS Filing Date
MAY 01, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2014 - ELITE PHARMACEUTICALS, INC.
Around the Web
- A Drug Maker Spends Big in Washington to Make Itself Heard
By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017
- Elite ex-soldiers are hiding in concert crowds to thwart terrorists
By The Sun - Tuesday Jul 18, 2017
Elite ex-soldiers are being hidden among crowds at music events to hunt down potential terrorists and avoid a repeat of the deadly Manchester bomb blast. The plain-clothed BDOs – Behavior Detection Officers – have a mission to watch out for red flags and “eliminate the threat.” Most of the officers, who are ex-military and police,...
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- The Mets just sent a loud statement that this is over
By Mike Vaccaro - Tuesday Jul 4, 2017
WASHINGTON — The question has ceased being if the Mets can actually catch up to the elite teams in the National League. The question has become something far simper than that: Do the Mets even belong on the same field with those teams? And the answer has become even more plain: No. They do not....